CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: When investigating CD34 expression on CML patient MDSCs we found that a median of 35% of MDSCs expressed CD34 demonstrating that some tumor cells may be accounted for as MDSCs (Figure 1B).